Faron Pharmaceuticals has decided to add new names to its board, for which the shareholders will decided in May.
The company Wednesday said it had proposed appointment of two new Non-Executive Directors, Dr. Gregory B. Brown and John Poulos, to its Board. May 16, 2017 will be the date when the shareholders will bring the final decision
Dr Frank Armstrong, Chairman of Faron, said “Dr Brown and Poulos will bring a wealth of global experience in the life sciences and investment community to strengthen the board, particularly from a US and commercial angle.
In addition, Faron also said that Dr Juho Jalkanen will, as of 16 May 2017, step down from the Board as Non-Executive Director, a position he has held since 2013. Dr Juho Jalkanen has this month been appointed to a new position of Vice President of Business Development of Faron and has joined the Management Team of the company.